FDA approves Merck RSV shot for infants to rival Sanofi AstraZeneca
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their…
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their…
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg…
Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the development and commercialization of advanced…